Mohan Bala Mersana Therapeutics, Inc. (MRSN) insider trading activity

MRSN Quotes by TradingView

Mohan Bala is SVP, Chief Development Officer of Mersana Therapeutics, Inc.. Currently has a direct ownership of 68,872 shares of MRSN, which is worth approximately $41,323. The most recent transaction as insider was on Jan 16, 2025, when has been sold 5,939 shares (Common Stock) at a price of $0.58 per share, resulting in proceeds of $3,444. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.9K
25.84% 3M change
390.12% 12M change
Total Value Held $41,323

Mohan Bala Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2025
SELL
Open market or private sale
$3,444 $0.58 p/Share
5,939 Reduced 7.94%
68,872 Common Stock
Jan 15 2025
BUY
Exercise of conversion of derivative security
-
14,583 Added 16.31%
74,811 Common Stock
Jan 14 2025
SELL
Open market or private sale
$2,146 $0.66 p/Share
3,253 Reduced 5.12%
60,228 Common Stock
Jan 13 2025
BUY
Exercise of conversion of derivative security
-
8,750 Added 12.11%
63,481 Common Stock
Oct 28 2024
SELL
Open market or private sale
$3,579 $1.9 p/Share
1,884 Reduced 3.33%
54,731 Common Stock
Oct 25 2024
BUY
Exercise of conversion of derivative security
-
6,250 Added 9.94%
56,615 Common Stock
Oct 03 2024
SELL
Open market or private sale
$10,972 $1.96 p/Share
5,598 Reduced 10.0%
50,365 Common Stock
Oct 02 2024
SELL
Open market or private sale
$16,178 $2.0 p/Share
8,089 Reduced 12.63%
55,963 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
-
50,000 Added 43.84%
64,052 Common Stock
Jan 16 2024
SELL
Open market or private sale
$9,298 $2.71 p/Share
3,431 Reduced 19.62%
14,052 Common Stock
Jan 13 2024
BUY
Exercise of conversion of derivative security
-
8,750 Added 33.35%
17,483 Common Stock
Oct 26 2023
SELL
Open market or private sale
$2,160 $1.13 p/Share
1,912 Reduced 17.96%
8,733 Common Stock
Oct 25 2023
BUY
Exercise of conversion of derivative security
-
6,250 Added 36.99%
10,645 Common Stock
MB

Mohan Bala

SVP, Chief Development Officer
Cambridge, MA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRSN